SCHEMBL19939334

SCHEMBL19939334

N#Cc1cccc(-c2ccc(-c3cccc4cccc(-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc5)c34)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK4 Q9HAZ1 4/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ CYP1A2 P05177 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ CYP2C19 P33261 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ HSD17B10 Q99714 3/20 0.48
▸ TSHR P16473 2/20 0.48
▸ CYP2D6 P10635 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ ALDH1A3 P47895 1/20 0.46
▸ MAPK1 P28482 2/20 0.45
▸ GABRG2 P18507 2/20 0.45
▸ GABRB3 P28472 2/20 0.45
▸ GABRA5 P31644 2/20 0.45
▸ GABRA3 P34903 2/20 0.45
▸ GABRA1 P14867 1/20 0.45
▸ ABCG2 Q9UNQ0 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21131861 0.97 CLK4 (0.46) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL22986955 0.96 CYP1A2 (0.48) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL19939325 0.96 CYP1A2 (0.49) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL19942096 0.93 MEN1 (0.43) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL19942098 0.92 MEN1 (0.44) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL19942328 0.90 ABCG2 (0.48) ALDH1A3GABRG2GABRB3GABRA5GABRA3
SCHEMBL26411896 0.89 MEN1 (0.42) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL19939307 0.89 CYP1A2 (0.56) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL20405351 0.89 CLK4 (0.50) CLK4MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL19939337 0.89 CLK4 (0.50) CLK4MEN1ALDH1A1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210305516-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-09-30 — — US disclosed
US-20210050528-A1 ORGANIC LIGHT EMITTING DIODE LG CHEM, LTD. (KR) 2021-02-18 — — US disclosed
EP-3595025-B1 ORGANIC LIGHT EMITTING ELEMENT LG CHEMICAL LTD (KR) 2020-12-30 — — EP disclosed
US-20180066180-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2018-03-08 — — US disclosed
US-20180066180-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210305516-A1 ORGANIC LIGHT-EMITTING DEVICE AOC2, RUVBL2, RUVBL1 CLK4 976/4885MEN1 2195/4885ALDH1A1 155/4885
US-20180066180-A1 ORGANIC LIGHT-EMITTING DEVICE CRY1, CRY2, PPOX CLK4 2929/4885MEN1 2120/4885ALDH1A1 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback